The Center for Drug Discovery is a resource for investigators in all Baylor College of Medicine departments and will complement efforts in the Department of Pharmacology, the Gulf Coast Consortia, and the Institute for Clinical and Translational Research as well as other departments and centers at Baylor College of Medicine. The CDD is integral to the Experimental Therapeutics initiative at Baylor College of Medicine.
The CDD includes a state-of-the-art screening facility to perform screening for a wide range of cell-based phenotypic and target-based biochemical assays in high-throughput or follow-up screens.
This vital resource will work closely with Baylor scientists to develop and perform primary screens. Once assays have been validated with small drug libraries, larger screens can be performed with the help of the Gulf Coast Consortia. Secondary validation assays and additional assays with newly synthesized analogs will also be performed in the center.
View information on the methodologies we use on the path to discovery webpage.
Center For Drug Discovery Leadership
- Martin M. Matzuk, M.D., Ph.D.
- Damian W. Young, Ph.D.
Center Assistant Director
- Conrad Santini, Ph.D.
Group Leader of Synthetic Chemistry
- Nicholas Simmons, Ph.D.
DNA-encoded Chemistry Technology (DEC-Tec) Platform Leader
- Kevin MacKenzie, Ph.D.
- Richard N. Sifers, Ph.D.
Director of Operations and Membership
- Kimberly Kerlec
High-Throughput Screening Platform Co-Director
- Zhifeng Yu, Ph.D.
DEC-Tec Selection Leader
- Justin Larn Anglin, Ph.D.
Medicinal Chemistry Leader